Clinical Trials Directory

Trials / Conditions / Retinopathy of Prematurity

Retinopathy of Prematurity

125 registered clinical trials studyying Retinopathy of Prematurity13 currently recruiting.

StatusTrialSponsorPhase
CompletedAutomated Screening Device to Detect MTMROP
NCT06517836
Siloam VisionN/A
RecruitingImaging Retinal Vasculature in Infant Eyes
NCT05558059
Duke University
RecruitingImpact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
NCT06672913
Baskent University Ankara HospitalN/A
Active Not RecruitingValidation of i-ROP DL to Detect More Than Mild ROP
NCT06109285
Siloam VisionN/A
Not Yet RecruitingReducing Pain and Increasing Comfort During a Retinopathy of Prematurity Examination
NCT06348641
Nurgül TekinN/A
RecruitingAn Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Us
NCT06315556
Bayer
CompletedComfort Level in Premature Infants Undergoing Retinopathy of Prematurity Screening
NCT07016984
Istanbul Nisantasi UniversityN/A
UnknownPeripheral Avascular Retina in Retinopathy of Prematurity
NCT06044181
Assiut UniversityN/A
UnknownNeO2Matic-Pilot Trial
NCT05629910
Rigshospitalet, DenmarkN/A
RecruitingIntranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
NCT06067958
Assaf-Harofeh Medical CenterPhase 3
RecruitingEvaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in
NCT06265363
Baskent University Ankara Hospital
UnknownThe Effect of Different Music Listened During Retinopathy Examination to Premature Infants
NCT05967572
Necmettin Erbakan UniversityN/A
RecruitingA Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blo
NCT05705258
Bayer
CompletedA 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Parti
NCT05576792
Novartis Pharmaceuticals
CompletedEffect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of
NCT06461975
Alexandria UniversityPhase 3
RecruitingOral Propranolol for Prevention of Threshold Retinopathy of Prematurity
NCT03083431
University of ZurichPhase 2
UnknownReal World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retino
NCT04985448
Chengdu Kanghong Biotech Co., Ltd.
CompletedA Study Investigating Whether Low Dose Eyedrops for Pupil Dilation is as Effective and Safe as Standard Dose E
NCT06288321
The University of Hong KongEARLY_Phase 1
CompletedRegulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity
NCT05304949
Novartis Pharmaceuticals
RecruitingPharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
NCT05387941
Region SkanePhase 1
Active Not RecruitingBevacizumab Treatment For Type 1 ROP
NCT04634578
Jaeb Center for Health ResearchPhase 2
CompletedIron and Retinopathy of Prematurity (ROP)
NCT05133999
Assistance Publique - Hôpitaux de Paris
TerminatedA Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
NCT04634604
Jaeb Center for Health ResearchPhase 3
UnknownClonidine as Pain Relief During ROP Eye Examinations
NCT04902859
Region Örebro CountyPhase 4
CompletedImprove Screening Criteria for Retinopathy of Prematurity in Two French Center
NCT05152862
Centre Hospitalier Sud Francilien
CompletedumBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematur
NCT05100212
Fondazione Policlinico Universitario Agostino Gemelli IRCCSPhase 2
CompletedEfficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
NCT05043077
Aristotle University Of ThessalonikiPhase 4
CompletedPrematurity and Ophthalmological Changes
NCT06452524
Ankara City Hospital Bilkent
RecruitingRetinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
NCT04995341
Duke UniversityN/A
RecruitingEuropean Disease Registry on Retinopathy of Prematurity (ROP)
NCT04939571
University Medicine Greifswald
CompletedFeasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos Californ
NCT06063863
University of NottinghamN/A
CompletedMother Milk as a Eye Drop & Premature Retinopathy
NCT04883931
Baskent UniversityN/A
CompletedThe Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
NCT05880433
Istanbul Training and Research Hospital
UnknownRole of Cord Blood Cytokines and Perinatal Factors in Prediction of Retinopathy of Prematurity
NCT04769661
Assiut University
UnknownThe Effect of Cycled Light on Premature Infants and Mothers
NCT05010252
National Taiwan University HospitalN/A
UnknownGenetic Polymorphism and Retinopathy of Prematurity: Correlation of Clinical Presentations and Severity
NCT05132257
Chang Gung Memorial Hospital
Active Not RecruitingExtension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopath
NCT04515524
Regeneron Pharmaceuticals
UnknownEye Shields for Infants After Dilated Exam
NCT04519060
Children's Hospital Los AngelesN/A
CompletedIntravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity
NCT05701124
Zagazig UniversityPhase 3
CompletedPhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retino
NCT04621136
Kyushu UniversityPhase 1 / Phase 2
UnknownThe Analysis of Association of Retinopathy of Prematurity, Gut Microbiome Profile, and Systemic Inflammation
NCT05144282
Chang Gung Memorial Hospital
CompletedThe Incidence of Treatment-requiring Retinopathy of Prematurity in Greece
NCT05099588
Aristotle University Of Thessaloniki
CompletedEfficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP)
NCT04623684
Aristotle University Of ThessalonikiPhase 4
CompletedA Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity
NCT05712642
Cairo UniversityPhase 3
CompletedPain Management During Screening for Retinopathy of Prematurity
NCT04767178
Istanbul Medeniyet University
CompletedPain of Premature Babies and RetCam (DOLICAM)
NCT04092127
University Hospital, Grenoble
CompletedStudy to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoag
NCT04101721
Regeneron PharmaceuticalsPhase 3
CompletedStress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided
NCT04408807
Aristotle University Of ThessalonikiN/A
UnknownZinc Supplementation on Very Low Birth Weight Infant
NCT04050488
Fakultas Kedokteran Universitas IndonesiaPhase 4
UnknownFasudil Eye Drop in Retinopathy Of Prematurity(ROP)
NCT04191954
Shahid Beheshti University of Medical SciencesPhase 2 / Phase 3
CompletedIntravitreal Ranibizumab in Recurrent ROP
NCT04539106
Ameera Gamal Abdelhameed
UnknownAnalysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity
NCT05186155
Chang Gung Memorial Hospital
CompletedAcupuncture for Preterm Infants Requiring Eye-exam
NCT03650621
University of AlbertaN/A
CompletedLong Term Outcome of Intravitreal Ranibizumab for ROP
NCT04537065
Ameera Gamal Abdelhameed
WithdrawnOptical Coherence Tomography Angiography (OCT-A) in Children (≥ 6 <14 Years of Age)
NCT03399825
Insel Gruppe AG, University Hospital Bern
Unknowna Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity
NCT03038295
Guangdong Women and Children HospitalPhase 2
CompletedAnalyzing Retinal Microanatomy in ROP
NCT02887157
Duke University
UnknownOral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants
NCT02977000
Huiqing SunN/A
CompletedIncidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey
NCT02814929
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
CompletedThe Effect of Eyemasks on Neonatal Stress Following Dilated Retinal Examination
NCT03824782
Sunnybrook Health Sciences CentreN/A
CompletedEnteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity
NCT02683317
Coordinación de Investigación en Salud, MexicoN/A
CompletedEfficacy of Mydriatic Drops in Premature Infants
NCT03448640
Bulent Ecevit University
WithdrawnPerformance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
NCT02655432
Université de Montréal
CompletedRAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Reti
NCT02375971
Novartis PharmaceuticalsPhase 3
CompletedEffects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Inf
NCT03154723
Huiqing SunN/A
CompletedStudy of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infa
NCT02820662
Centre Hospitalier Universitaire DijonN/A
CompletedSafety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-RO
NCT02504944
Meyer Children's Hospital IRCCSPhase 2
CompletedPhase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
NCT02390531
Jaeb Center for Health ResearchPhase 1
CompletedSynergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
NCT02344225
State University of New York - Downstate Medical CenterPhase 2
TerminatedTelemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation Project
NCT02257307
Children's Hospital of Philadelphia
CompletedOral Vitamin A Supplementation in Neonates With Birth Weight < 1500 g
NCT02102711
Francesca GarofoliN/A
CompletedOmega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for Th
NCT02486042
University of California, San DiegoPhase 2
CompletedCost-effectiveness of Tele-expertise for Premature Infants for Retinopathy
NCT02157727
Assistance Publique - Hôpitaux de Paris
CompletedInfant-parent Skin-to-skin Contact During Screening for Retinopathy
NCT02780544
St. Olavs HospitalN/A
CompletedREDEXAM - Reducing Painful Eye Examinations in Preterm Infants
NCT01861470
Newcastle-upon-Tyne Hospitals NHS Trust
CompletedSafety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature
NCT02014454
Meyer Children's Hospital IRCCSPhase 2
UnknownBevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1
NCT02090322
Universidad Autonoma de San Luis PotosíN/A
CompletedGenes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity
NCT01780155
National Institute of Environmental Health Sciences (NIEHS)
CompletedUK Surveillance of Treated Retinopathy of Prematurity
NCT02484989
Moorfields Eye Hospital NHS Foundation Trust
CompletedEffect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.
NCT03274596
Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesN/A
CompletedA Fatty Acids Study in Preventing Retinopathy of Prematurity
NCT02760472
Carola Pfeiffer-MosessonPhase 3
UnknownThe Efficacy of Paracetamol in Reducing Pain During Ophthalmological Examination for Retinopathy of Prematurit
NCT01872871
Dr. Sami Ulus Children's HospitalN/A
CompletedThe Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities
NCT01875510
Dr. Sami Ulus Children's HospitalN/A
CompletedWINROP Algorithm Validation for Retinopathy Screening in a Cohort of Premature Infants
NCT03347799
Central Hospital, Nancy, France
WithdrawnPan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
NCT01232777
Vision Research FoundationPhase 2
CompletedRegistry for Severe ROP and Treatment on Visual Outcomes
NCT01559571
Pediatrix
CompletedChanges in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomize
NCT04838665
University of the PhilippinesPhase 4
RecruitingClinical and Genetic Analysis of ROP
NCT04420156
Oregon Health and Science University
CompletedTelemedicine Approaches to Evaluating Acute-phase ROP
NCT01264276
Children's Hospital of Philadelphia
CompletedRefractive Error and Biometry in Retinopathy of Prematurity
NCT03334513
San Ni Chen
CompletedLucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
NCT02164604
Kantonsspital AarauN/A
TerminatedProparacaine and Mydriatic Eye Drops
NCT01266824
Children's Hospital of PhiladelphiaN/A
UnknownAutologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonat
NCT02050971
Pomeranian Medical University SzczecinPhase 1
TerminatedA Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
NCT01335113
Stanford University
CompletedOral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective S
NCT01238471
Rambam Health Care CampusPhase 1 / Phase 2
CompletedMulti-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
NCT01030575
NICHD Neonatal Research NetworkPhase 2
CompletedSafety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
NCT01079715
Meyer Children's Hospital IRCCSPhase 2 / Phase 3
CompletedSkin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
NCT00872664
University of UtahN/A
UnknownRecombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234
China Medical University HospitalPhase 1 / Phase 2
CompletedSucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening
NCT00921544
Coombe Women and Infants University HospitalPhase 4
TerminatedPan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
NCT00702819
Vision Research FoundationPhase 1
CompletedPain Response During Examination for Retinopathy of Prematurity
NCT00648687
National Bioethics Commission of BrazilN/A
UnknownBevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
NCT00622726
The University of Texas Health Science Center, HoustonPhase 2
CompletedInhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant
NCT00623220
Nabeel AliPhase 3
RecruitingAntiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
NCT00346814
Asociación para Evitar la Ceguera en MéxicoPhase 2 / Phase 3
WithdrawnVEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
NCT00563121
Asociación para Evitar la Ceguera en MéxicoPhase 4
TerminatedVascular Endothelial Growth Factor in Stage V ROP
NCT00500396
Asociación para Evitar la Ceguera en MéxicoPhase 4
CompletedVitamin A and Very Low Birthweight Babies (VitAL)
NCT00417404
Glasgow Royal InfirmaryPhase 4
CompletedTime Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants
NCT00845624
University of Virginia
UnknownCysteine Supplementation in Critically Ill Neonates
NCT00254176
University of California, Los AngelesPhase 2 / Phase 3
CompletedSingle-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
NCT00349726
NICHD Neonatal Research NetworkPhase 2
UnknownErythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001
Sheba Medical Center
TerminatedEfficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
NCT00634972
University of South AlabamaPhase 4
TerminatedUse of Sucrose to Relieve Pain During Eye Exams in Infants
NCT00161694
Weill Medical College of Cornell UniversityN/A
CompletedAppropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis
NCT01124331
University of SydneyN/A
CompletedSurfactant Positive Airway Pressure and Pulse Oximetry Trial
NCT00233324
NICHD Neonatal Research NetworkPhase 3
CompletedUltrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
NCT00279669
Weill Medical College of Cornell University
CompletedPain in Neonates During Screening for Retinopathy of Prematurity Using Two Methods
NCT00895869
NHS Lothian
UnknownThe Early Treatment for Retinopathy of Prematurity Study (ETROP)
NCT00027222
National Eye Institute (NEI)Phase 2 / Phase 3
CompletedRetinopathy of Prematurity:Summary of a Decade
NCT01363960
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
CompletedHeredity of Retinal Vessel Tortuosity
NCT00427063
Glostrup University Hospital, Copenhagen
CompletedThe Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
NCT00000156
National Eye Institute (NEI)Phase 3
CompletedSupplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
NCT01203436
NICHD Neonatal Research NetworkPhase 2 / Phase 3
CompletedCryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Premat
NCT00000133
National Eye Institute (NEI)N/A
No Longer AvailableUse of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of
NCT00870636
Children's Hospital Los Angeles